Shots: The termination of 2014 deal, is based on evaluation of portfolio and prioritization of assets within Janssen’s portfolio Janssen to support Geron involving transfer of ongoing clinical trials, regulatory, […]readmore
Tags : Janssen
Shots: This NDA is on basis of five pivotal studies: three short-term, one withdrawal maintenance of effect and one long-term safety, assessing (esketamine spray + a newly initiated oral antidepressant […]readmore
Regulatory
Janssen’s Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate
Shots: The approval is based on P-III SPARTAN study results assessing Erleada (240 mg,qd) vs PBO in 1,207 patients with NM-CRPC in ratio (2:1) in patients with (NM-CRPC) P-III SPARTAN […]readmore